Engraftment Syndrome After Autologous Stem Cell Transplant: Retrospective Review in Patients With Multiple Myeloma

Completed

• Conditions: Multiple Myeloma

• Registration Number: NCT01622582
• Lead Sponsor: University of Arkansas

Brief Summary

Engraftment Syndrome after Autologous Stem Cell Transplant: Retrospective Review in Patients with Multiple Myeloma

Detailed Description

A retrospective chart review series will be performed fpr subjects enrolled from 1/1/2006.

Study Timeline

• Study Start: 2006-01
• Study First Submitted: 2012-06-15
• Study First Submitted QC: 2012-06-18
• Study First Posted: 2012-06-19
• Primary Completion: 2013-03
• Study Completion: 2013-03
• Status Verified: 2015-03
• Last Update Submitted: 2015-03-02
• Last Update Posted: 2015-03-03

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 796

Inclusion Criteria

• Patients with Multiple Myeloma, developing engraftment syndrome

Exclusion Criteria

• Patients with Multiple Myeloma, with no features of engraftment syndrome

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
number of patients developing Engraftment syndrome following stem cell transplant	6 months post-transplant	A retrospective review where subjects medical records are studied for development of engraftment syndrome 6 months after stem cell transplant

Trial Locations

Locations (1)

University of Arkansas for Medical Sciences; 🇺🇸 Little Rock, Arkansas, United States